In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substances

Cancer Immunology, Immunotherapy

Volumn 53, Issue 5, 2004, Pages 383-390

  Ishii, Ritsuko ^a   Shimizu, Masumi ^a   Nakagawa, Yohko ^a   Shimizu, Kazuo ^a   Tanaka, Shigeo ^a   Takahashi, Hidemi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acid eluted substances; CD1d; Dendritic cells; Hepatoma; NKT cells

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; ACID; CD1 ANTIGEN; HLA ANTIGEN CLASS 1; PEPTIDE FRAGMENT;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL FRACTIONATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ELUTION; FEMALE; HEPATOMA CELL; IMMUNIZATION; ISOGRAFT; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIZATION; SPLEEN; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ACIDS; ANIMALS; ANTIGENS, CD1; BONE MARROW; CARCINOMA, HEPATOCELLULAR; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNIZATION; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, ISOGENEIC; TUMOR CELLS, CULTURED;

EID: 2342540949     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0453-0     Document Type: Article

References (30)

1. Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E (1997) Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 186:1177
2. Bannai M, Kawamura T, Naito T, Kameyama H, Abe T, Kawamura H, Tsukada C, Watanabe H, Hatakeyama K, Hamada H, Nishiyama Y, Ishikawa H, Takeda K, Okumura K, Taniguchi M, Abo T (2001) Abundance of unconventional CD8(+) natural killer T cells in the large intestine. Eur J Immunol 31:3361
3. Blanc D, Bron C, Gabert J, Letourneur F, MacDonald HR, Malissen B (1988) Gene transfer of the Ly-3 chain gene of the mouse CD8 molecular complex: co-transfer with the Ly-2 polypeptide gene results in detectable cell surface expression of the Ly-3 antigenic determinants. Eur J Immunol 18:613
4. Boczkowski D, Nair SK, Snyder D, Gilboa E (1996) Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184:465
5. Brenner M, Porcelli S (1997) Antigen presentation: a balanced diet. Science 277:332
6. Fields RC, Shimizu K, Mule JJ (1998) Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci USA 95:9482
7. Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP (1997) Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 3:483
8. Gong J, Chen D, Kashiwaba M, Kufe D (1997) Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 3:558
9. Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T, Koezuka Y, Porcelli SA, Cardell S, Brenner MB, Behar SM (2000) Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211
10. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693
11. Kugler A, Stuhler G, Walden P, Zoller G, Zobywalski A, Brossart P, Trefzer U, Ullrich S, Muller CA, Becker V, Gross AJ, Hemmerlein B, Kanz L, Muller GA, Ringert RH (2000) Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med 6:332
12. Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM (1999) Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg 90:1115
13. Melief CJ, Van Der Burg SH, Toes RE, Ossendorp F, Offringa R (2002) Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunol Rev 188:177
14. Mowat AM, Donachie AM (1991) Studies on the immunogenicity of an endogenously processed protein antigen in mice. Immunol Lett 27:243
15. Nair SK, Snyder D, Rouse BT, Gilboa E (1997) Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int J Cancer 70:706
16. Nakatsuka K, Sugiyama H, Nakagawa Y, Takahashi H (1999) Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells. J Hepatol 30:1119
17. Roark JH, Park SH, Jayawardena J, Kavita U, Shannon M, Bendelac A (1998) CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol 160:3121
18. Rojo JM, Kerner JD, Janeway CA, Jr. (1989) Selective induction of growth factor production and growth factor receptor expression by different signals to a single T cell. Eur J Immunol 19:2061
19. Sacchi A, Falcioni R, Tibursi G, Apollonj Ghetti C (1988) MHC antigens expressed on 3LL metastatic variants: correlation with the expression of a TSP-180 protein. Adv Exp Med Biol 233:141
20. Schild HJ, Kyewski B, Von Hoegen P, Schirrmacher V (1987) CD4+ helper T cells are required for resistance to a highly metastatic murine tumor. Eur J Immunol 17:1863
21. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R (2001) Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2:947
22. Schuler G, Steinman RM (1997) Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 186:1183
23. Sentman CL, Hackett J, Jr., Moore TA, Tutt MM, Bennett M, Kumar V (1989) Pan natural killer cell monoclonal antibodies and their relationship to the NK1.1 antigen. Hybridoma 8:605
24. Storkus WJ, Zeh HJ 3rd, Salter RD, Lotze MT (1993) Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother 14:94
25. Takahashi H, Cohen J, Hosmalin A, Cease KB, Houghten R, Cornette JL, DeLisi C, Moss B, Germain RN, Berzofsky JA (1988) An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci USA 85:3105
26. Takahashi H (1993) Antigen processing and presentation. Microbiol Immunol 37:1
27. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int Immunol 5:849
28. Takahashi H, Nakagawa Y, Leggatt GR, Ishida Y, Saito T, Yokomuro K, Berzofsky JA (1996) Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism? J Exp Med 183:879
29. Toura I, Kawano T, Akutsu Y, Nakayama T, Ochiai T, Taniguchi M (1999) Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J Immunol 163:2387
30. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87